BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10355394)

  • 1. A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations.
    McCarthy PM; Yared JP; Foster RC; Ogella DA; Borsh JA; Cosgrove DM
    Ann Thorac Surg; 1999 May; 67(5):1268-73. PubMed ID: 10355394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Card Surg; 2003; 18(2):140-6. PubMed ID: 12757341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery: a prospective randomized study.
    Collart F; Caus T; Pomane C; Pellissier V; Chi Y; Montiès JR; Mesana T
    Artif Organs; 2000 Aug; 24(8):611-3. PubMed ID: 10971246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin.
    Nilsson J; Scicluna S; Malmkvist G; Pierre L; Algotsson L; Paulsson P; Bjursten H; Johnsson P
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):834-9. PubMed ID: 22914806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-controlled evaluation of the Medtronic Resting Heart System compared with conventional cardiopulmonary bypass in patients undergoing isolated coronary artery bypass surgery.
    Nozohoor S; Johnsson P; Scicluna S; Wallentin P; Andell E; Nilsson J
    Interact Cardiovasc Thorac Surg; 2012 May; 14(5):599-604. PubMed ID: 22286599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system, endothelial damage, and cytokine release in patients with cardiac operation employing aprotinin and steroids.
    Inui K; Shimazaki Y; Watanabe T; Takahashi T; Minowa T; Takeda H; Yanagawa N; Sotoda Y
    Artif Organs; 1999 Dec; 23(12):1107-12. PubMed ID: 10619929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting.
    Jansen PG; Baufreton C; Le Besnerais P; Loisance DY; Wildevuur CR
    Ann Thorac Surg; 1996 May; 61(5):1363-6. PubMed ID: 8633942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'High dose' aprotinin and heparin-coated circuits: clinical efficacy and inflammatory response.
    Parolari A; Alamanni F; Gherli T; Salis S; Spirito R; Foieni F; Rossi F; Bertera A; Oddono P; Biglioli P
    Cardiovasc Surg; 1999 Jan; 7(1):117-27. PubMed ID: 10073771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass.
    Lundblad R; Moen O; Fosse E
    Ann Thorac Surg; 1997 May; 63(5):1361-7. PubMed ID: 9146328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.